These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 31361829)

  • 21. Performance of open-fronted microbiological safety cabinets: the value of operator protection tests during routine servicing.
    Osborne R; Durkin T; Shannon H; Dornan E; Hughes C
    J Appl Microbiol; 1999 Jun; 86(6):962-70. PubMed ID: 10389245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Open fronted safety cabinets in ventilated laboratories.
    Clark RP; Osborne RW; Pressey DC; Grover F; Keddie JR; Thomas C
    J Appl Bacteriol; 1990 Sep; 69(3):338-58. PubMed ID: 2246141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mayo Clinic approaches to meet United States Pharmacopeia <797> requirements for facility design and environmental controls of nuclear pharmacy.
    Hung JC; Anderson MM
    J Nucl Med; 2009 Jan; 50(1):156-64. PubMed ID: 19091891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microbiological safety cabinets: selection, installation, testing and use.
    Kennedy DA; Collins CH
    Br J Biomed Sci; 2000; 57(4):330-7. PubMed ID: 11204866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surface contamination with antineoplastic agents in six cancer treatment centers in Canada and the United States.
    Connor TH; Anderson RW; Sessink PJ; Broadfield L; Power LA
    Am J Health Syst Pharm; 1999 Jul; 56(14):1427-32. PubMed ID: 10428450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continued successful operation of open-fronted microbiological safety cabinets in a force-ventilated laboratory.
    Osborne RW; Durkin TA
    J Appl Bacteriol; 1991 Nov; 71(5):434-8. PubMed ID: 1761437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of cell sorting aerosols and containment by an optical airborne particle counter.
    Xie M; Waring MT
    Cytometry A; 2015 Aug; 87(8):784-9. PubMed ID: 26012776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. End-preparation assessments and tests for compounded sterile preparations.
    McElhiney LF
    Int J Pharm Compd; 2013; 17(4):307-11. PubMed ID: 24261146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reducing workplace cytotoxic surface contamination using a closed-system drug transfer device.
    Siderov J; Kirsa S; McLauchlan R
    J Oncol Pharm Pract; 2010 Mar; 16(1):19-25. PubMed ID: 19965949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of computer-assisted biohazard safety cabinet for preparation and verification of injectable anticancer agents.
    Okayasu S; Nakamura M; Sugiyama T; Chigusa K; Sakurai K; Matsuura K; Yamamoto M; Kinosada Y; Itoh Y
    Chemotherapy; 2009; 55(4):234-40. PubMed ID: 19468221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Environmental contamination, product contamination and workers exposure using a robotic system for antineoplastic drug preparation.
    Sessink PJ; Leclercq GM; Wouters DM; Halbardier L; Hammad C; Kassoul N
    J Oncol Pharm Pract; 2015 Apr; 21(2):118-27. PubMed ID: 24567041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Demystifying dynamic smoke pattern tests for sterile compounding pharmacies.
    Rhoads R; Exner L; Wagner JT
    Am J Health Syst Pharm; 2020 Jan; 77(1):56-60. PubMed ID: 31756250
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of microbiological containment systems on dexterity.
    Sawyer J; Bennett A; Haines V; Elton E; Crago K; Speight S
    J Occup Environ Hyg; 2007 Mar; 4(3):166-73. PubMed ID: 17237022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multicenter evaluation of a new closed system drug-transfer device in reducing surface contamination by antineoplastic hazardous drugs.
    Bartel SB; Tyler TG; Power LA
    Am J Health Syst Pharm; 2018 Feb; 75(4):199-211. PubMed ID: 29339374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Biological safety in virological field with special considerations on class II biological safety cabinets].
    Hino S
    Uirusu; 2006 Dec; 56(2):193-9. PubMed ID: 17446668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sterilization of a biological safety cabinet by vaporized KMT reagent.
    Kida N; Mochizuki Y; Taguchi F
    Biocontrol Sci; 2007 Jun; 12(2):65-9. PubMed ID: 17629248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Collison 6-jet nebulizer: choice for the certification test of the class II biological safety cabinet.
    Hino S; Sato H
    Jpn J Exp Med; 1984 Feb; 54(1):29-38. PubMed ID: 6482058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patterns and characteristics associated with surface contamination of hazardous drugs in hospital pharmacies.
    Salch SA; Zamboni WC; Zamboni BA; Eckel SF
    Am J Health Syst Pharm; 2019 Apr; 76(9):591-598. PubMed ID: 31361828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Choosing a Vial Processing Line for Aseptic Compounding: Part 1.
    Noorian S; Vahedi N
    Int J Pharm Compd; 2016; 20(4):283-292. PubMed ID: 28333673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analytic Methods Used in Quality Control in a Compounding Pharmacy.
    Allen LV
    Int J Pharm Compd; 2017; 21(1):31-37. PubMed ID: 28346196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.